Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1128/IAI.05497-11 | ||||
| Año | 2012 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Salmonella enterica serovar Enteritidis causes a systemic, typhoid-like infection in newly hatched poultry and mice. In the present study, a library of 54,000 transposon mutants of S. Enteritidis phage type 4 (PT4) strain P125109 was screened for mutants deficient in the in vivo colonization of the BALB/c mouse model using a microarray-based negative-selection screening. Mutants in genes known to contribute to systemic infection (e.g., Salmonella pathogenicity island 2 [SPI-2], aro, rfa, rfb, phoP, and phoQ) and enteric infection (e.g., SPI-1 and SPI-5) in this and other Salmonella serovars displayed colonization defects in our assay. In addition, a strong attenuation was observed for mutants in genes and genomic islands that are not present in S. Typhimurium or in most other Salmonella serovars. These genes include a type I restriction/modification system (SEN4290 to SEN4292), the peg fimbrial operon (SEN2144A to SEN2145B), a putative pathogenicity island (SEN1970 to SEN1999), and a type VI secretion system remnant SEN1001, encoding a hypothetical protein containing a lysin motif (LysM) domain associated with peptidoglycan binding. Proliferation defects for mutants in these individual genes and in exemplar genes for each of these clusters were confirmed in competitive infections with wild-type S. Enteritidis. A Delta SEN1001 mutant was defective for survival within RAW264.7 murine macrophages in vitro. Complementation assays directly linked the SEN1001 gene to phenotypes observed in vivo and in vitro. The genes identified here may perform novel virulence functions not characterized in previous Salmonella models.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | SILVA-VALENZUELA, CECILIA ALEJANDRA | Mujer |
Universidad de Chile - Chile
|
| 2 | BLONDEL-BUIJUY, CARLOS JOSE | Hombre |
Universidad de Chile - Chile
|
| 3 | QUEZADA-BUSTOS, CAROLINA PAZ | Mujer |
Universidad de Chile - Chile
|
| 4 | Porwollik, S. | Hombre |
Vaccine Res Inst San Diego - Estados Unidos
Vaccine Research Institute of San Diego - Estados Unidos |
| 5 | ANDREWS-POLYMENIS, HELENE LOUISE | Mujer |
Texas A&M Univ Syst Hlth Sci Ctr - Estados Unidos
Texas A and M Health Science Center - Estados Unidos |
| 6 | TORO-UGALDE, CECILIA SHIRLEY | Mujer |
Universidad de Chile - Chile
|
| 7 | ZALDIVAR-SAN ROMAN, MARIA MERCEDES | Mujer |
Universidad de Chile - Chile
|
| 8 | CONTRERAS-OSORIO, LUCIA INES | Mujer |
Universidad de Chile - Chile
|
| 9 | McClelland, Michael | Hombre |
Vaccine Res Inst San Diego - Estados Unidos
Univ Calif Irvine - Estados Unidos Vaccine Research Institute of San Diego - Estados Unidos University of California, Irvine - Estados Unidos |
| 10 | SANTIVIAGO-CID, CARLOS ALBERTO | Hombre |
Universidad de Chile - Chile
|
| Fuente |
|---|
| FONDECYT |
| CONICYT |
| NIH |
| World Bank |
| National Institute of Allergy and Infectious Diseases |
| Vicerrectoria de Asuntos Academicos, Departamento de Postgrado y Postitulo, Universidad de Chile |
| AFRI CSREES |
| Agradecimiento |
|---|
| This work was supported in part by grants 1100092 and 1110172 from FONDECYT and grant ADI-08/2006 from CONICYT and The World Bank. M.M. and H.L.A.-P. were supported in part by NIH grants R21AI083964, R01AI083646, R56AI077645, and R01AI075093 and AFRI CSREES grant 2009-03579. C.A.S. and C.J.B. were supported by fellowships from CONICYT and from Vicerrectoria de Asuntos Academicos, Departamento de Postgrado y Postitulo, Universidad de Chile. |